Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab

We herein report a 75-year-old man with non-small-cell lung cancer who developed tubulointerstitial nephritis due to pembrolizumab administration. He was successfully treated with atezolizumab following steroid administration. He was initially diagnosed with lung adenocarcinoma (T1bN3M1b, stage IV),...

Descripción completa

Detalles Bibliográficos
Autores principales: Taki, Takahiro, Oda, Naohiro, Fujioka, Yusuke, Mitani, Reo, Tokura, Takehiko, Takata, Ichiro, Oshiro, Yoshiyuki, Takigawa, Nagio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402961/
https://www.ncbi.nlm.nih.gov/pubmed/32269191
http://dx.doi.org/10.2169/internalmedicine.4260-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402961/
https://www.ncbi.nlm.nih.gov/pubmed/32269191
http://dx.doi.org/10.2169/internalmedicine.4260-19

Ejemplares similares